| The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies E Carreras, C Dufour, M Mohty, N Kröger Springer Nature, 2019 | 398 | 2019 |
| Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ... The Lancet 396 (10266), 1885-1894, 2020 | 292 | 2020 |
| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 273 | 2021 |
| COVID-19 outcomes in patients with hematologic disease F Malard, A Genthon, E Brissot, Z van de Wyngaert, Z Marjanovic, S Ikhlef, ... Bone marrow transplantation 55 (11), 2180-2184, 2020 | 195 | 2020 |
| Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy R Duléry, S Lamure, M Delord, R Di Blasi, A Chauchet, T Hueso, C Rossi, ... American journal of hematology 96 (8), 934-944, 2021 | 134 | 2021 |
| Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study R Dulery, J Salleron, A Dewilde, J Rossignol, EM Boyle, J Gay, ... Biology of Blood and Marrow Transplantation 18 (7), 1080-1089, 2012 | 131 | 2012 |
| Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies F Malard, B Gaugler, J Gozlan, L Bouquet, D Fofana, L Siblany, D Eshagh, ... Blood cancer journal 11 (8), 142, 2021 | 125 | 2021 |
| Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia G Battipaglia, A Ruggeri, R Massoud, J El Cheikh, M Jestin, A Antar, ... Cancer 123 (15), 2867-2874, 2017 | 116 | 2017 |
| Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria G Battipaglia, F Malard, MT Rubio, A Ruggeri, AC Mamez, E Brissot, ... Haematologica 104 (8), 1682, 2019 | 113 | 2019 |
| Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia J Rossignol, AS Michallet, L Oberic, M Picard, A Garon, C Willekens, ... Leukemia 25 (3), 473-478, 2011 | 92 | 2011 |
| Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation R Duléry, R Mohty, M Labopin, S Sestili, F Malard, E Brissot, G Battipaglia, ... Cardio Oncology 3 (2), 250-259, 2021 | 88 | 2021 |
| Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous … A de Masson, M Beylot-Barry, JD Bouaziz, RP de Latour, F Aubin, ... haematologica 99 (3), 527, 2014 | 83 | 2014 |
| Sequential conditioning with thiotepa in T cell-replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with … R Duléry, AL Ménard, S Chantepie, J El-Cheikh, S François, J Delage, ... Biology of Blood and Marrow Transplantation 24 (5), 1013-1021, 2018 | 73 | 2018 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 71 | 2022 |
| Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study S Lamure, R Dulery, R Di Blasi, A Chauchet, C Laureana, B Deau-Fischer, ... EClinicalMedicine 27, 2020 | 66 | 2020 |
| Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma RW Merryman, L Castagna, L Giordano, VT Ho, P Corradini, A Guidetti, ... Leukemia 35 (9), 2672-2683, 2021 | 65 | 2021 |
| UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a … R Benjamin, N Jain, MV Maus, N Boissel, C Graham, A Jozwik, D Yallop, ... The Lancet Haematology 9 (11), e833-e843, 2022 | 63 | 2022 |
| Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of … A Renneville, RB Abdelali, S Chevret, O Nibourel, M Cheok, C Pautas, ... Oncotarget 5 (4), 916, 2014 | 60 | 2014 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 57 | 2022 |
| Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis T Hueso, AS Godron, E Lanoy, J Pacanowski, LI Levi, E Gras, L Surgers, ... Leukemia 36 (4), 1025-1034, 2022 | 55 | 2022 |
